Main Session
Sep
30
SS 40 - Hem 2: New Protocols, New Paradigms: Clinical Trials Shaping the Future of Hematologic RT
Decreasing the Dose of Consolidation Radiation Therapy in DLBCL/HGBL: A Phase II Trial by the International Lymphoma Radiation Oncology Group
Presenter(s)
Christopher Kelsey, MD, FASTRO - Duke University Medical Center, Durham, North Carolina